VolitionRx (VNRX) News Today $0.56 -0.03 (-5.07%) (As of 12/4/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period VolitionRx (NYSE:VNRX) Coverage Initiated by Analysts at StockNews.comStockNews.com assumed coverage on shares of VolitionRx in a research report on Thursday. They issued a "sell" rating for the company.November 28, 2024 | marketbeat.comVolitionRx (NYSE:VNRX) Earns "Hold" Rating from BenchmarkNovember 24, 2024 | americanbankingnews.comBenchmark Reaffirms Hold Rating for VolitionRx (NYSE:VNRX)Benchmark reiterated a "hold" rating on shares of VolitionRx in a research note on Friday.November 22, 2024 | marketbeat.comVolitionRx (NYSE:VNRX) Now Covered by Analysts at StockNews.comStockNews.com started coverage on VolitionRx in a research report on Wednesday. They set a "sell" rating on the stock.November 20, 2024 | marketbeat.comVolitionRx reports Q3 revenue up 187% year-over-year to $475KNovember 16, 2024 | markets.businessinsider.comVolitionRX Ltd (VNRX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...November 16, 2024 | finance.yahoo.comVolitionRx Limited (VNRX) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | seekingalpha.comVolitionRx Limited Announces Third Quarter 2024 Financial Results and Business UpdateNovember 14, 2024 | prnewswire.comVolitionRx (NYSE:VNRX) Coverage Initiated at StockNews.comStockNews.com assumed coverage on shares of VolitionRx in a research note on Tuesday. They set a "sell" rating on the stock.November 12, 2024 | marketbeat.comVolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business UpdateNovember 8, 2024 | prnewswire.comVolition Appoints Timothy I. Still as ChairmanNovember 6, 2024 | prnewswire.comVolitionRx (NYSE:VNRX) Now Covered by StockNews.comStockNews.com initiated coverage on VolitionRx in a research report on Monday. They issued a "sell" rating for the company.November 4, 2024 | marketbeat.comMultiple studies show Nu.Q® NETs test could predict sepsis patients at risk of deterioratingOctober 31, 2024 | prnewswire.comVolition to share new 'NETs in sepsis management' data insights at upcoming webinarOctober 9, 2024 | prnewswire.comVolition hosts NETs in sepsis management symposium at ESICM Lives 2024October 3, 2024 | prnewswire.comVolition Appoints Dr. Ethel Rubin as an Independent DirectorSeptember 30, 2024 | prnewswire.comVolitionRx (NYSE:VNRX) Earns Sell Rating from Analysts at StockNews.comStockNews.com initiated coverage on VolitionRx in a research note on Wednesday. They set a "sell" rating for the company.September 25, 2024 | marketbeat.comVolitionRx (NYSE:VNRX) Receives New Coverage from Analysts at StockNews.comStockNews.com assumed coverage on shares of VolitionRx in a research report on Tuesday. They set a "sell" rating on the stock.September 17, 2024 | marketbeat.comVolition Hosts KOL Roundtable on SepsisSeptember 11, 2024 | prnewswire.comInsider Buying: VolitionRx Limited (NYSE:VNRX) Director Buys 150,000 Shares of StockAugust 22, 2024 | insidertrades.comVolitionRx Limited (VNRX) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | seekingalpha.comVolitionRx Limited Announces Second Quarter 2024 Financial Results and Business UpdateAugust 14, 2024 | prnewswire.comVolitionRX Q2 2024 Earnings PreviewAugust 14, 2024 | msn.comVolitionRx Announces Pricing of up to $21.5 Million Registered Direct OfferingAugust 9, 2024 | prnewswire.comVolitionRx Limited Schedules Second Quarter 2024 Earnings Conference Call and Business UpdateAugust 6, 2024 | prnewswire.comVolitionRx (NYSE:VNRX) Research Coverage Started at StockNews.comStockNews.com initiated coverage on VolitionRx in a report on Wednesday. They set a "sell" rating on the stock.July 31, 2024 | marketbeat.comVolition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensingJuly 9, 2024 | prnewswire.comStockNews.com Initiates Coverage on VolitionRx (NYSE:VNRX)StockNews.com began coverage on shares of VolitionRx in a research note on Saturday. They issued a "sell" rating for the company.June 29, 2024 | marketbeat.comVolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual MeetingJune 27, 2024 | prnewswire.comVolitionRx Limited (NYSE:VNRX) Forecasted to Earn Q2 2024 Earnings of ($0.09) Per ShareVolitionRx Limited (NYSE:VNRX - Free Report) - Research analysts at Zacks Small Cap lifted their Q2 2024 earnings estimates for shares of VolitionRx in a research report issued to clients and investors on Tuesday, June 25th. Zacks Small Cap analyst S. Ralston now expects that the company will earJune 27, 2024 | marketbeat.comVolitionRx Limited to Present at Jefferies Global Healthcare ConferenceMay 29, 2024 | prnewswire.comCantor Fitzgerald Reiterates Overweight Rating for VolitionRx (NYSE:VNRX)Cantor Fitzgerald reissued an "overweight" rating and issued a $2.50 target price on shares of VolitionRx in a report on Thursday.May 16, 2024 | marketbeat.comVolitionRX Ltd (VNRX) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances and ...May 15, 2024 | finance.yahoo.comVolitionRX: Q1 Earnings SnapshotMay 13, 2024 | washingtonpost.comVolitionRx Limited Announces First Quarter 2024 Financial Results and Business UpdateMay 13, 2024 | prnewswire.comVolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business UpdateMay 8, 2024 | prnewswire.comResearch Analysts Set Expectations for VolitionRx Limited's FY2024 Earnings (NYSE:VNRX)VolitionRx Limited (NYSE:VNRX - Free Report) - Equities researchers at Zacks Small Cap issued their FY2024 earnings per share estimates for shares of VolitionRx in a research report issued to clients and investors on Monday, April 8th. Zacks Small Cap analyst S. Ralston anticipates that the compaApril 10, 2024 | marketbeat.comVolitionRx Limited Forecasted to Post Q1 2024 Earnings of ($0.11) Per Share (NYSE:VNRX)VolitionRx Limited (NYSE:VNRX - Free Report) - Equities research analysts at Zacks Small Cap issued their Q1 2024 earnings estimates for shares of VolitionRx in a research report issued to clients and investors on Monday, April 8th. Zacks Small Cap analyst S. Ralston anticipates that the companyApril 9, 2024 | marketbeat.comVNRX: VolitionRx Reports 2023 Results; Distribution of Nu.Q Vet Test Expanding; Nu.Q Discover Growing; Two Key R&D Efforts in 2024/25: 1) Breakthrough Cancer Detection Method ...April 8, 2024 | msn.comVNRX: VolitionRx Reports 2023 Results; Distribution of Nu.Q Vet Test Expanding; Nu.Q Discover Growing; Two Key R&D Efforts in 2024/25: 1) Breakthrough Cancer Detection Method (Capture -PCR) 2) Nu.Q NET for SepsisApril 8, 2024 | finance.yahoo.comVolitionRx's (VNRX) Overweight Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating and set a $2.50 price objective on shares of VolitionRx in a report on Wednesday.March 27, 2024 | marketbeat.comVolitionRx (NYSE:VNRX) Releases Earnings ResultsVolitionRx (NYSE:VNRX - Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.11) EPS for the quarter. VolitionRx had a negative net margin of 5,201.69% and a negative return on equity of 7,185.73%.March 26, 2024 | marketbeat.comVNRX Stock Earnings: VolitionRX Meets EPS, Misses Revenue for Q4 2023March 25, 2024 | msn.comVolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business UpdateMarch 25, 2024 | prnewswire.comEarnings Outlook For VolitionRXMarch 22, 2024 | benzinga.comVolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business UpdateMarch 21, 2024 | prnewswire.comVolitionRx Limited: Volition appoints Dr Andrew Retter as Chief Medical OfficerMarch 21, 2024 | finanznachrichten.deVolitionRx Names Andrew Retter Chief Medical OfficerMarch 19, 2024 | markets.businessinsider.comVolition appoints Dr Andrew Retter as Chief Medical OfficerMarch 19, 2024 | finance.yahoo.comVolitionRX LtdMarch 19, 2024 | money.usnews.com Get VolitionRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Coins Set to Soar with a Pro-Crypto White House (Ad)Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over $3 Million worth of crypto – and he's not the only one at the top interested in digital assets… Click here to reserve your free seat at the Crypto Community Summit VNRX Media Mentions By Week VNRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VNRX News Sentiment▼0.590.86▲Average Medical News Sentiment VNRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VNRX Articles This Week▼11▲VNRX Articles Average Week Get VolitionRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MOLN News BNTC News CMPX News MGNX News SLDB News ADCT News STRO News XBIT News DMAC News SOPH News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:VNRX) was last updated on 12/4/2024 by MarketBeat.com Staff From Our PartnersLock in this share price before 12/5When the team that built Zillow into a $16B real estate leader launches a new company, it’s worth paying atten...Pacaso | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredStrange: Why is Amazon suddenly yielding 39.70%?Something big is happening with Amazon stock… While most investors collect ZERO dividends from Amazon… A...Investors Alley | SponsoredThis frightening chart explains everything going on in the economy (see photo)Why the wealth gap is getting wider — with the one percenters growing ever richer and ever more powerful, whil...Banyan Hill Publishing | SponsoredThe 2024 TECH RESETAre we on the edge of the biggest ‘TECH RESET’ in decades?InvestorPlace | SponsoredMeet the NYSE traded company behind a potentially blockbuster antiviral drugThis public company’s one lead drug alone, NV-387, potentially addresses a $2.5 to $4.3 billion market Imag...Smallcaps Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VolitionRx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share VolitionRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
